Interleukin 35 Protein (IL35) (AA 23-215, AA 23-228) (Fc Tag)
Quick Overview for Interleukin 35 Protein (IL35) (AA 23-215, AA 23-228) (Fc Tag) (ABIN7566268)
抗原
See all Interleukin 35 (IL35) 蛋白蛋白类型
生物活性
宿主
资源
纯度
-
-
产品特性
- AA 23-215, AA 23-228
-
标记
- This Interleukin 35 protein is labelled with Fc Tag.
-
原理
- IL-35 (mouse):Fc (human) (rec.)
-
交叉反应
- 小鼠
-
产品特性
- A soluble dimeric fusion protein consisting of the extracellular domain of mouse IL12a subunit (aa 23-215) is fused to the Fc region of human IgG1, and the mouse Ebi3 subunit (aa 23-228) linked to IL12a by disulfide bonds.
-
过滤
- Sterile filtered
-
内毒素水平
- <1EU/mg protein (LAL test, Lonza).
-
Biological Activity Comment
- Bioactivity was measured in a cell proliferation assay of Con A activated mouse splenocytes.
-
-
Interleukin 35 (IL35) (AA 21-229), (AA 23-219) (Active) protein (His tag)
IL35 宿主: 人 宿主: 大肠杆菌（E. Coli） > 97 % AcA, CC Active
-
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
缓冲液
- Lyophilized from 0.2μm-filtered solution in PBS.
-
注意事项
- Avoid freeze/thaw cycles.Centrifuge lyophilized vial before opening and reconstitution.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Use & Stability: Stable for at least 1 year after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.
-
-
- Interleukin 35 (IL35)
-
别名
- IL-35
-
背景
-
Interleukin-35
Interleukin-35 (IL-35) is a novel IL-12 family cytokine produced by regulatory T cells (Treg) but not by resting or activated effector T cells (Teff). IL-35 is a heterodimeric protein composed of EBI3 (Epstein-Barr-Virus-induced gene 3) and IL-12a (p35). EBI3 is a downstream target of Foxp3, a transcription factor required for Treg-cell development and function, and thus Treg-cell restriction of IL35 occurs. Regulatory T cells are essential for maintaining self tolerance and preventing autoimmunity, and IL-35 is identified as a molecule that mediates the immune suppression function of Treg-cell. As an inhibitory cytokine, IL-35 induces proliferation of Treg-cell populations but suppresses Th17 cell development. Studies in mice show the absence of either IL-35 chain from Treg-cell reduces the cells' ability to suppress inflammation using an experimental model for inflammatory bowel disease. IL-35 is suggested as a potential target of immunotherapy. Recently, insufficient IL-35 levels were shown to play a pivotal role in the development of type 1 diabetes (T1D) and autoimmune diseases.
-
分子量
- ~30-60kDa
-
NCBI登录号
- NP_032377
抗原
-
